Key facts
- This page summarizes Jules A. Musing's Form 4 filing for TherapeuticsMD, Inc. (TXMD).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 22 Aug 2022, 06:00.
Jules A. Musing - 18 Aug 2022 Form 4 Insider Report for TherapeuticsMD, Inc. (TXMD)
- Reporting relationship
- Director
- Issuer ticker
- TXMD
- Reported as of
- 18 Aug 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 22 Aug 2022, 06:00:51 UTC
- Prior SEC filing
- 12 Aug 2021
- Next SEC filing
- 03 Oct 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jules A. Musing
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jules A. Musing filed Form 4 for TherapeuticsMD, Inc. (TXMD) on 22 Aug 2022.
Change
- Previous filing in this sequence was filed on 12 Aug 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TXMD
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +1,984
- Change %
- +97%
- Price
- Shares after
- 4,022
- Date
- 18 Aug 2022
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TXMD
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -1,984
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 18 Aug 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,984
- Exercise price
- $0.000000
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
On August 18, 2022, the reporting person received 1,984 shares of common stock of the issuer in settlement of restricted stock units (RSUs), which vested on July 1, 2022.
Footnote F2
Each RSU represents a contingent right to receive one share of issuer common stock upon settlement.
Footnote F3
The RSUs vested on July 1, 2022.